These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29884453)

  • 1. Long-term and clinical profile of heart failure with recovered ejection fraction in a non-tertiary hospital.
    Martínez-Mateo V; Fernández-Anguita M; Cejudo L; Martín-Barrios E; Paule AJ
    Med Clin (Barc); 2019 Jan; 152(2):50-54. PubMed ID: 29884453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictive variables for mortality in elderly patients hospitalized due to heart failure with preserved ejection fraction].
    Carrasco-Sánchez FJ; Páez-Rubio MI; García-Moreno JM; Vázquez-García I; Araujo-Sanabria J; Pujo-de la Llave E
    Med Clin (Barc); 2013 Nov; 141(10):423-9. PubMed ID: 23790575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of atrial fibrillation on the mortality of patients with heart failure with preserved ejection fraction.
    Franco J; Formiga F; Cepeda J; Llacer P; Arévalo-Lorido J; Cerqueiro J; González-Franco A; Epelde F; Manzano L; Montero Pérez-Barquero M;
    Med Clin (Barc); 2018 May; 150(10):376-382. PubMed ID: 28870424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo acute heart failure: Clinical features and one-year mortality in the Spanish nationwide Registry of Acute Heart Failure.
    Franco J; Formiga F; Corbella X; Conde-Martel A; Llácer P; Álvarez Rocha P; Ormaechea Gorricho G; Satué J; Soler Rangel L; Manzano L; Montero-Pérez-Barquero M; ;
    Med Clin (Barc); 2019 Feb; 152(4):127-134. PubMed ID: 30712652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of carvedilol therapy in patients with heart failure with preserved ejection fraction - Results from the Croatian heart failure (CRO-HF) registry.
    Domagoj M; Branka JZ; Jelena M; Davor M; Duska G
    Med Clin (Barc); 2019 Jan; 152(2):43-49. PubMed ID: 29678315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and long-term prognosis in patients with chronic heart failure and reduced ejection fraction in China.
    Liu X; Yu H; Pei J; Chu J; Pu J; Zhang S
    Heart Lung Circ; 2014 Sep; 23(9):818-26. PubMed ID: 24881031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial.
    Florea VG; Rector TS; Anand IS; Cohn JN
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities, risk factors and outcomes in patients with heart failure and an ejection fraction of more than or equal to 40% in primary care- and hospital care-based outpatient clinics.
    Eriksson B; Wändell P; Dahlström U; Näsman P; Lund LH; Edner M
    Scand J Prim Health Care; 2018 Jun; 36(2):207-215. PubMed ID: 29633886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics and one-year outcomes in elderly patients hospitalised with heart failure and preserved, mid-range and reduced ejection fraction].
    González-Guerrero JL; Paredes-Galán E; Ferrero-Martínez AI; Galán MC; Hornillos-Calvo M; Menéndez-Colino R; Torres-Torres I; Rodríguez-Artalejo F; Rodríguez-Pascual C
    Rev Esp Geriatr Gerontol; 2020; 55(4):195-200. PubMed ID: 32081386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential prognostic impact of type 2 diabetes mellitus in women and men with heart failure with preserved ejection fraction.
    Palau P; Bertomeu-González V; Sanchis J; Soler M; de la Espriella R; Domínguez E; Santas E; Núñez E; Chorro FJ; Miñana G; Bayés-Genís A; Núñez J
    Rev Esp Cardiol (Engl Ed); 2020 Jun; 73(6):463-470. PubMed ID: 31629690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes.
    Basuray A; French B; Ky B; Vorovich E; Olt C; Sweitzer NK; Cappola TP; Fang JC
    Circulation; 2014 Jun; 129(23):2380-7. PubMed ID: 24799515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Anxiety Between Heart Failure With Reduced Ejection Fraction and Heart Failure With Preserved Ejection Fraction.
    Lin TK; Hsu BC; Li YD; Chen CH; Lin JW; Chien CY; Weng CY
    J Am Heart Assoc; 2019 Jun; 8(12):e010739. PubMed ID: 31181979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
    Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
    BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
    Lund LH; Claggett B; Liu J; Lam CS; Jhund PS; Rosano GM; Swedberg K; Yusuf S; Granger CB; Pfeffer MA; McMurray JJV; Solomon SD
    Eur J Heart Fail; 2018 Aug; 20(8):1230-1239. PubMed ID: 29431256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction.
    Fernández-Vázquez D; Ferrero-Gregori A; Álvarez-García J; Gómez-Otero I; Vázquez R; Delgado Jiménez J; Worner Diz F; Bardají A; García-Pavía P; Bayés-Genís A; González-Juanatey JR; Cinca J; Pascual Figal DA
    Rev Esp Cardiol (Engl Ed); 2020 Jul; 73(7):561-568. PubMed ID: 31974070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse J-Curve Relationship Between On-Treatment Blood Pressure and Mortality in Patients With Heart Failure.
    Lee SE; Lee HY; Cho HJ; Choe WS; Kim H; Choi JO; Jeon ES; Kim MS; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Kim JJ; Oh BH
    JACC Heart Fail; 2017 Nov; 5(11):810-819. PubMed ID: 29096790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etiology of Heart Failure and Outcomes in Patients Hospitalized for Acute Decompensated Heart Failure With Preserved or Reduced Ejection Fraction.
    Kajimoto K; Minami Y; Sato N; Kasanuki H;
    Am J Cardiol; 2016 Dec; 118(12):1881-1887. PubMed ID: 27720439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings.
    Agra Bermejo R; Cordero A; García-Acuña JM; Gómez Otero I; Varela Román A; Martínez Á; Álvarez Rodríguez L; Abou-Jokh C; Rodríguez-Mañero M; Cid Álvarez B; López-Palop R; Carrillo P; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):820-828. PubMed ID: 29249471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.